Related Articles
Anti‑BCMA CAR‑T cell immunotherapy for relapsed or refractory multiple myeloma
Lenalidomide use in multiple myeloma (Review)
Ibrutinib in CLL/SLL: From bench to bedside (Review)
Combination therapy: A feasibility strategy for CAR‑T cell therapy in the treatment of solid tumors (Review)
Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)